Long-term Safety Follow-up Study in the Prevention of Bronchiolitis Obliterans Syndrome (BOS)

Summary

The purpose of this study is to evaluate long-term safety of L-CsA in prevention of bronchiolitis obliterans syndrome (BOS) following lung transplantation (LTx) in patients previously enrolled in phase II/III L-CsA clinical trial 12011.201.

Timeline

Start

2012-02

Primary completion

2013-07

Completion

2014-12

Outcome

Outcome not reported

Stopped: “Core study 12011.201 was terminated.”

Drugs

Indications